Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kanlaya, Rattiyaporn ^a   Khamchun, Supaporn ^a   Kapincharanon, Chompunoot ^a   Thongboonkerd, Visith ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; EPIGALLOCATECHIN GALLATE; OXALIC ACID DERIVATIVE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2;

ANALOGS AND DERIVATIVES; ANIMAL; DOG; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; GENETICS; HUMAN; KIDNEY TUBULE; MDCK CELL LINE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CATECHIN; DOGS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMANS; KIDNEY TUBULES; MADIN DARBY CANINE KIDNEY CELLS; NF-E2-RELATED FACTOR 2; OXALATES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84979643088     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30233     Document Type: Article

References (44)

1. Vilayur, E., Harris, D. C. Emerging therapies for chronic kidney disease: what is their role Nat. Rev. Nephrol. 5, 375-383 (2009).
2. Brosnahan, G., Fraer, M. Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing. South. Med J. 103, 140-146 (2010).
3. Guarino, M., Tosoni, A., Nebuloni, M. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum. Pathol. 40, 1365-1376 (2009).
4. Flier, S. N. et al. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol. Chem. 285, 20202-20212 (2010).
5. Zeisberg, M., Kalluri, R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol. Med (Berl). 82, 175-181 (2004).
6. Kalluri, R., Neilson, E. G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin. Invest 112, 1776-1784 (2003).
7. Zeisberg, M., Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J Clin. Invest 119, 1429-1437 (2009).
8. Liu, Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am. Soc. Nephrol. 15, 1-12 (2004).
9. Xu, J., Lamouille, S., Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172 (2009).
10. Strutz, F. et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 130, 393-405 (1995).
11. Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin. Invest 110, 341-350 (2002).
12. Rastaldi, M. P. et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 62, 137-146 (2002).
13. Ivanova, L., Butt, M. J., Matsell, D. G. Mesenchymal transition in kidney collecting duct epithelial cells. Am. J Physiol Renal Physiol 294, F1238-F1248 (2008).
14. Liu, M. et al. Novel evidence demonstrates that epithelial-mesenchymal transition contributes to nephrolithiasis-induced renal fibrosis. J Surg. Res. 182, 146-152 (2013).
15. Singh, B. N., Shankar, S., Srivastava, R. K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 82, 1807-1821 (2011).
16. Ferrazzano, G. F., Amato, I., Ingenito, A., De Natale, A., Pollio, A. Anti-cariogenic effects of polyphenols from plant stimulant beverages (cocoa, coffee, tea). Fitoterapia 80, 255-262 (2009).
17. Hannig, C., Sorg, J., Spitzmuller, B., Hannig, M., Al Ahmad, A. Polyphenolic beverages reduce initial bacterial adherence to enamel in situ. J Dent. 37, 560-566 (2009).
18. Melgarejo, E., Medina, M. A., Sanchez-Jimenez, F., Urdiales, J. L. Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br. J Pharmacol. 158, 1705-1712 (2009).
19. Osterburg, A., Gardner, J., Hyon, S. H., Neely, A., Babcock, G. Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol ( )-epigallocatechin-3-gallate (EGCG). Clin. Microbiol. Infect. 15, 341-346 (2009).
20. Arts, I. C., van De, P. B., Hollman, P. C. Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agric. Food Chem. 48, 1752-1757 (2000).
21. Yao, K. et al. Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Mol. Vis. 14, 217-223 (2008).
22. Itoh, Y. et al. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol. 173, 271-275 (2005).
23. Jeong, B. C., Kim, B. S., Kim, J. I., Kim, H. H. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol. 20, 356-361 (2006).
24. Kim, H. K., Yang, T. H., Cho, H. Y. Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World J Gastroenterol. 15, 5200-5205 (2009).
25. Sriram, N., Kalayarasan, S., Sudhandiran, G. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm. Pharmacol. Ther. 22, 221-236 (2009).
26. Kanlaya, R., Fong-ngern, K., Thongboonkerd, V. Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion. J Proteomics 80C, 55-65 (2013).
27. Coe, F. L., Parks, J. H., Asplin, J. R. The pathogenesis and treatment of kidney stones. N. Engl. J Med. 327, 1141-1152 (1992).
28. Rashed, T., Menon, M., Thamilselvan, S. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am. J Nephrol. 24, 557-568 (2004).
29. Rhyu, D. Y. et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelialmesenchymal transition in renal tubular epithelial cells. J Am. Soc. Nephrol. 16, 667-675 (2005).
30. Zhang, A., Dong, Z., Yang, T. Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells. Am. J Physiol Renal Physiol 291, F1332-F1342 (2006).
31. Kitamura, M. et al. Epigallocatechin gallate suppresses peritoneal fibrosis in mice. Chem. Biol. Interact. 195, 95-104 (2012).
32. Na, H. K., Surh, Y. J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem. Toxicol. 46, 1271-1278 (2008).
33. Miao, W., Hu, L., Scrivens, P. J., Batist, G. Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes. J Biol. Chem. 280, 20340-20348 (2005).
34. Sang, S. et al. Synthesis and structure identification of thiol conjugates of ()-epigallocatechin gallate and their urinary levels in mice. Chem. Res. Toxicol. 18, 1762-1769 (2005).
35. Na, H. K. et al. ( )-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch. Biochem. Biophys. 476, 171-177 (2008).
36. Huang, Y., Li, W., Su, Z. Y., Kong, A. N. The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nutr. Biochem. 26, 1401-1413 (2015).
37. Shin, D. H. et al. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic. Biol. Med. 48, 1051-1063 (2010).
38. Kang, K. W. Angiotensin II-mediated Nrf2 down-regulation: a potential causing factor for renal fibrosis Arch. Pharm. Res. 34, 695-697 (2011).
39. Ruiz, S., Pergola, P. E., Zager, R. A., Vaziri, N. D. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 83, 1029-1041 (2013).
40. Zhou, P. et al. Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. Mol. Med Rep. 7, 1096-1102 (2013).
41. Sahin, K. et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 87, 240-245 (2010).
42. Kobayashi, M. et al. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int. 68, 1018-1031 (2005).
43. Rindler, M. J., Chuman, L. M., Shaffer, L., Saier, M. H. Jr. Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK). J Cell Biol. 81, 635-648 (1979).
44. Saier, M. H. Jr. Growth and differentiated properties of a kidney epithelial cell line (MDCK). Am. J Physiol 240, C106-C109 (1981).